SCHEMBL854401

SCHEMBL854401

CCCCCNc1nc(C)c(Cc2ccccc2OCC)c(N)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 11/20 0.42
KCNH3 Q9ULD8 1/20 0.41
TLR8 Q9NR97 3/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
DHFR P00374 1/20 0.39
CSNK1A1 P48729 1/20 0.38
CSNK1D P48730 1/20 0.38
PRKCD Q05655 1/20 0.38
PAK1 Q13153 1/20 0.38
CAMK2B Q13554 1/20 0.38
CAMK2G Q13555 1/20 0.38
CAMK2D Q13557 1/20 0.38
TAOK1 Q7L7X3 1/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL854515 0.90 TLR7 (0.52) TLR7TLR8CYP1A2
SCHEMBL854702 0.88 HRH1 (0.46) TLR7TLR8MAPT
SCHEMBL28873208 0.87 TLR7 (0.55) TLR7TLR8CYP1A2
SCHEMBL3697314 0.83 TLR8 (0.61) TLR7TLR8
SCHEMBL19056407 0.80 TLR7 (0.40) TLR7TLR8MAPTL3MBTL1
SCHEMBL853783 0.76 TLR7 (0.45) TLR7TLR8MAPTDHFRTSHR
SCHEMBL853744 0.74 TLR7 (0.46) TLR7MAPTDHFR
SCHEMBL854178 0.74 ALDH1A1 (0.51) TLR7TLR8NPSR1DHFR
SCHEMBL853209 0.74 DHFR (0.59) TLR7TLR8DHFR
SCHEMBL853346 0.74 TLR7 (0.47) TLR7KCNH3TLR8DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2432768-A1 NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND FURTHER DISEASES AstraZeneca AB (SE) 2012-03-28 EP disclosed
WO-2010133885-A1 NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND FURTHER DISEASES ASTRAZENECA AB (SE) 2010-11-25 WO disclosed